Rising Pharma Holdings, INC is an industry leader in marketing and distributing innovative branded and multi-source prescription and over-the-counter pharmaceutical products. Our many commercial products cross a variety of therapeutic areas and multiple dosage forms. We have a robust emerging pipeline of pharmaceutical products through the development of Abbreviated New Drug Applications (ANDA) filed,or in the process of being filed,with the FDA. Rising is committed to providing our customers with high quality pharmaceuticals. Our products are manufactured in state-of-the-art, FDA approved facilities using quality assurance techniques that meet regulatory standards. Through our close partnerships with our customers throughout the United States, we ensure the safe and effective delivery of our products to the public. Our leading management team of industry experts is dedicated towards continued innovation in drug development, marketing and distribution.
Looking for a particular Rising Pharmaceuticals employee's phone or email?
The Rising Pharmaceuticals annual revenue was $9.3 million in 2026.
James Mastakas is the CFO of Rising Pharmaceuticals.
242 people are employed at Rising Pharmaceuticals.
Rising Pharmaceuticals is based in East Brunswick, New Jersey.
The NAICS codes for Rising Pharmaceuticals are [325, 42, 3254, 32541, 424, 32].
The SIC codes for Rising Pharmaceuticals are [28, 283].